Research Areas

With a nationwide Donor Network of over 70,000 individuals and robust donor data, we efficiently collect biospecimens tailored to your study criteria. Covering more than 100 conditions across eight therapeutic areas, we can provide the majority of minimally invasive samples you require. Our proven track record includes a 93% delivered-to-plan rate, meaning 93% of samples are delivered according to the original, agreed upon plan. Explore below to discover more about our Donor Network for each therapeutic area.

Autoimmune and Inflammatory Disorders

Autoimmune and inflammatory disorders are our largest contingency of donors - over 30,000. More than 35 conditions covering the more common such as allergies and Crohn's disease to rather rare including giant cell arteritis (GCA) and autoimmune hepatitis (AIH). Our success rate as described by delivered to plan is over 93% with over 400 studies completed.

Arthritis

Atopic Dermatitis (Eczema)

Autoimmune Hepatitis (AIH)

Behcet's Disease

Celiac Disease

CIDP (Chronic inflammatory demyelinating

polyneuropathy)

Cirrhosis

Crohn's Disease

Endometriosis

Fibromyalgia

Graves' Disease

Giant Cell Arteritis (GCA)

Gout

Hashimoto's Disease

Hidradenitis Suppurativa

Lupus (SLE)

Lupus Nephritis

Myositis

Osteoarthritis

Pemphigus/Pemphigoid

Polymyalgia Rheumatica (PMR)

Primary Biliary Cholangitis (Cirrhosis)

Psoriasis

Psoriatic Arthritis

Rheumatoid Arthritis

Rosacea

Systemic

Sclerosis/Scleroderma

Sjogren's Syndrome

Thyroid Eye Disease

Ulcerative Colitis

Vasculitis

Vitiligo

Cardiovascular Diseases

Our Donor Network with diagnosed cardiovascular diseases is almost 1000 individuals. These are challenging studies to recruit, but with our expertise in feasibility, we have delivered a 100% of planned projects.

Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Atherosclerosis

Atrial Fibrillation/Arrhythmia

Coronary Artery Disease

Heart Failure

Myocardial Infarction (Heart Attack)

Genetic Diseases

Genetic diseases encompass 9 conditions and over 1400 donors. Through collaborations with nonprofit organizations and patient advocacy groups, we've successfully completed rare disease projects, including Fabry disease. With over 50 projects delivered and a 92% on-plan success rate, we're proud to drive progress in genetic and rare disease research.

Age-related Macular Degeneration (AMD)

Cystic Fibrosis

DMD (Duchenne Muscular Dystrophy)

Fabry Disease

Huntington's Disease

Mucopolysaccaridosis (MPS) I, MPS II- Hunter syndrome, MPS III- Sanfilippo syndrome

Polycystic Kidney Disease (PKD)

Retinitis Pigmentosa

Trisomy 21

Hematological Diseases

Infectious Diseases

Neurological Conditions

We currently have seven neurological conditions with over 3000 individuals. Patient-reported outcomes as well as interactions with caregivers can be especially important with some of these conditions. Our success in finding the samples planned is over 98%.

Alzheimer's Disease

Amyotrophic lateral sclerosis (ALS)

Dravet Syndrome

Multiple Sclerosis

Myasthenia Gravis

Parkinson's Disease

Stroke

Oncology

We have over 3500 donors (and growing) in our network who have been diagnosed with a type of cancer. We have completed over 30 studies with 88% delivered to plan.

Breast Cancer

Cervical Cancer

Colorectal Cancer (CRC)

Kidney Cancer

Leukemia

Lung Cancer

Lymphoma

Melanoma

Multiple Myeloma

Myelofibrosis

Myeloproliferative Neoplasms (MPN)

Ovarian Cancer

Pancreatic Cancer

Polycythemia Vera

Prostate Cancer

Respiratory and Metabolic Conditions

Respiratory and metabolic conditions is our third largest community (behind autoimmune and healthy) with almost 13,000 individuals. We have had great success with 100% delivered to plan.